Budesonide Inhalant
Product Images NDC 76282-641

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 76282-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 01

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 02

This text includes information about a medication regimen consisting of taking 0.25 mg of Placebo once a day and 10 mg once a day of an unspecified medication. The text also includes numbered sections but without sufficient context or further information.Usage or meaning could not be determined from the given text.*

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 03

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 04

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 05

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 06

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 07

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 08

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 09

This is a description of a medication called Budesonide Inhalation Suspension, which is packaged in a single-dose ampule. It is for inhalation only and contains 0.25 mg of micronized budesonide. The usual dosage is not specified, but instructions indicate that one opened ampule should be used immediately in a nebulizer, and ampules should be stored properly. The text also indicates that the medication should be used as directed by a physician and should be kept out of the reach of children. The lot number and expiration date are provided.*

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 10

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 11

This is a medication called Budesonide in inhalation suspension form. The foil envelope containing single-dose ampules should be opened and used within two weeks. This medication is meant for inhalation use only and should not be discarded until the last ampule has been used. The provided text unfortunately provides no further details about the use or indications of this medication.*

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 12

Budesonide Inhalation Suspension is a medication meant for inhalation purposes only. The text includes dosage-specific information and mentions the product is stored in single-dose Rxonly ampules per pack.*

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 13

The text describes a medication called Budesonide in inhalation suspension form. The medication is meant for inhalation only and is contained in single-dose ampules. The medication is provided in a envelope that contains five ampules. The medication has a prescription label and has an expiration date. The text also includes a warning not to discard the foil envelope until the last ampule is taken. The rest of the text is not clear or not readable.*

FDA Label Image

Bb2e8526 80f5 4cee Ab3b Fb80dfc3241e 14

This is a pharmaceutical product description for Budesonide Inhalation Suspension. The product is intended for inhalation only and contains 1 mg/2 mL of the suspension. It also mentions a store location at 17 Store St.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.